Active Metalloproteases of the A Disintegrin And Metalloprotease (ADAM) Family: Biological Function and Structure

被引:140
作者
Klein, Theo [1 ]
Bischoff, Rainer [1 ]
机构
[1] Univ Groningen, Dept Pharm, NL-9700 AD Groningen, Netherlands
关键词
metalloprotease; integrin; ADAM-17; function; proteolysis; TUMOR-NECROSIS-FACTOR; ALPHA-CONVERTING-ENZYME; CYSTEINE-RICH DOMAIN; SPERM-EGG FUSION; 12 MELTRIN ALPHA; MESSENGER-RNA EXPRESSION; MATERNAL SERUM ADAM12; RENAL-CELL CARCINOMA; TNF-ALPHA; CATALYTIC-ACTIVITY;
D O I
10.1021/pr100556z
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The "a disintegrin and metalloproteases" (ADAMs) are membrane-anchored metzincins of the adamalysin subfamily. This review gives an overview over the biological function and structure of ADAMs focusing on members of the family that display proteolytic activity. ADAMs are involved in a range of human diseases such as cancer metastasis, inflammatory disorders, neurological disease or asthma. It is, however, often difficult to assign a definitive role to a specific member of the ADAM family in a given disease mechanism due to overlapping activities and redundancy in function, as shown in various knock-out studies. The review discusses the structural domains that are not directly linked to protease activity followed by a more detailed overview over the role of the metalloprotease domain. Different family members are critically reviewed with respect to their role in biological processes with particular emphasis on disease-relevant functions.
引用
收藏
页码:17 / 33
页数:17
相关论文
共 250 条
  • [1] The transmembrane CXC-chemokine ligand 16 is induced by IFN-γ and TNF-α and shed by the activity of the disintegrin-like metalloproteinase ADAM10
    Abel, S
    Hundhausen, C
    Mentlein, R
    Schulte, A
    Berkhout, TA
    Broadway, N
    Hartmann, D
    Sedlacek, R
    Dietrich, S
    Muetze, B
    Schuster, B
    Kallen, KJ
    Saftig, P
    Rose-John, S
    Ludwig, A
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (10) : 6362 - 6372
  • [2] Involvement of a disintegrin and a metalloproteinase 8 (ADAM8) in osteoclastogenesis and pathological bone destruction
    Ainola, M.
    Li, T-F
    Mandelin, J.
    Hukkanen, M.
    Choi, S. J.
    Salo, J.
    Konttinen, Y. T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (03) : 427 - 434
  • [3] Increased expression of disintegrin-metalloproteinases ADAM-15 and ADAM-9 following upregulation of integrins α5β1 and αvβ3 in atherosclerosis
    Al-Fakhri, N
    Wilhelm, J
    Hahn, M
    Heidt, M
    Hehrlein, FW
    Endisch, AM
    Hupp, T
    Cherian, SM
    Bobryshev, YV
    Lord, RSA
    Katz, N
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 89 (04) : 808 - 823
  • [4] Alfa CisseM., 2007, J NEUROSCI, V27, P4083
  • [5] The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs
    Amour, A
    Knight, CG
    English, WR
    Webster, A
    Slocombe, PM
    Knäuper, V
    Docherty, AJP
    Becherer, JD
    Blobel, CP
    Murphy, G
    [J]. FEBS LETTERS, 2002, 524 (1-3) : 154 - 158
  • [6] TNF-α converting enzyme (TACE) is inhibited by TIMP-3
    Amour, A
    Slocombe, PM
    Webster, A
    Butler, M
    Knight, CG
    Smith, BJ
    Stephens, PE
    Shelley, C
    Hutton, M
    Knäuper, V
    Docherty, AJP
    Murphy, G
    [J]. FEBS LETTERS, 1998, 435 (01) : 39 - 44
  • [7] Regulation of the α-secretase ADAM10 by its prodomain and proprotein convertases
    Anders, A
    Gilbert, S
    Garten, W
    Postina, R
    Fahrenholz, F
    [J]. FASEB JOURNAL, 2001, 15 (08) : 1837 - +
  • [8] Putative function of ADAM9, ADAM10, and ADAM17 as APP α-secretase
    Asai, M
    Hattori, C
    Szabó, B
    Sasagawa, N
    Maruyama, K
    Tanuma, S
    Ishiura, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 301 (01) : 231 - 235
  • [9] Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
    Asakura, M
    Kitakaze, M
    Takashima, S
    Liao, Y
    Ishikura, F
    Yoshinaka, T
    Ohmoto, H
    Node, K
    Yoshino, K
    Ishiguro, H
    Asanuma, H
    Sanada, S
    Matsumura, Y
    Takeda, H
    Beppu, S
    Tada, M
    Hori, M
    Higashiyama, S
    [J]. NATURE MEDICINE, 2002, 8 (01) : 35 - 40
  • [10] ADAM15 decreases integrin αvβ3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion
    Beck, V
    Herold, H
    Benge, A
    Luber, B
    Hutzler, P
    Tschesche, H
    Kessler, H
    Schmitt, M
    Geppert, HG
    Reuning, U
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2005, 37 (03) : 590 - 603